| 1. |
|
|
| 2. |
- Scarlett, Alan G., et al.
(författare)
-
Do distributions of diamondoid hydrocarbons accumulated in oil-contaminated fish tissues help to identify the sources of oil?
- 2024
-
Ingår i: MARINE POLLUTION BULLETIN. - 0025-326X .- 1879-3363. ; 198
-
Tidskriftsartikel (refereegranskat)abstract
- Identifying the sources of environmental oil contamination can be challenging, especially for oil in motile organisms such as fish. Lipophilic hydrocarbons from oil can bioaccumulate in fish adipose tissue and potentially provide a forensic "fingerprint" of the original oil. Herein, diamondoid hydrocarbon distributions were employed to provide such fingerprints. Indices produced from diamondoids were used to compare extracts from fish adipose tissues and the crude and fuel oils to which the fish were exposed under laboratory conditions. A suite of 20 diamondoids was found to have bioaccumulated in the dietary-exposed fish. Cross-plots of indices between fish and exposure oils were close to the ideal 1:1 relationship. Comparisons with diamondoid distributions of nonexposure oils produced overall, but not exclusively, weaker correlations. Linear Discriminatory Analysis on a combined set of 15 diamondoid and bicyclane molecular ratios was able to identify the exposure oils, so a use of both compound classes is preferable.
|
|
| 3. |
- Spilsbury, Francis, et al.
(författare)
-
Defining the data gap: What do we know about environmental exposure, hazards and risks of pharmaceuticals in the European aquatic environment?
- 2024
-
Ingår i: WATER RESEARCH. - 0043-1354 .- 1879-2448. ; 251
-
Tidskriftsartikel (refereegranskat)abstract
- Active pharmaceutical ingredients (APIs) and their transformation products inevitably enter waterways where they might cause adverse effects to aquatic organisms. Identifying the potential risks of APIs in the environment is therefore a goal and current strategic direction of environmental management described in the EU Strategic Approach to Pharmaceuticals in the Environment and the Green Deal. This is challenged by a paucity of monitoring and ecotoxicity data to adequately describe risks. In this study we analyze measured environmental concentrations (MECs) of APIs from 5933 sites in 25 European countries as documented in the EMPODAT database or collected by the German Environment Agency for the time period between 1997 and 2020. These data were compared with empirical data on the ecotoxicity of APIs from the U.S. EPA ECOTOX database. Although 1763 uniquely identifiable APIs are registered with the European Medicines Agency (EMA) for sale in the European Economic Area (EEA), only 312 (17.7%) of these are included in publicly available monitoring data, 36 (1.8%) compounds have sufficient ecotoxicological data to derive a PNEC, and only 27 (1.5%) compounds meet both the hazard and exposure data requirements required to to perform an environmental risk assessment according to EMA guidelines. Four of these compounds (14.8%) had a median risk quotient (RQ) > 1. Endocrine disruptors had the highest median RQ, with 7.0 and 5.6 for 17 alpha ethinyl-estradiol and 17 beta-estradiol respectively. A comparison of in-silico and empirical exposure data for 72 APIs demonstrated the high protectiveness of the current EMA guidelines, with predicted environmental concentrations (PECs) exceeding median MECs in 98.6% of cases, with a 100-fold median increase. This study describes the data shortfalls hindering an accurate assessment of the risk posed to European waterways by APIs, and identifies 68 APIs for prioritized inclusion in monitoring programs, and 66 APIs requiring ecotoxicity testing to fill current data gaps.
|
|
| 4. |
- Spilsbury, Francis, et al.
(författare)
-
Ecotoxicological mixture risk assessment of 35 pharmaceuticals in wastewater effluents following post-treatment with ozone and/or granulated activated carbon
- 2024
-
Ingår i: Science of the Total Environment. - 0048-9697. ; 906
-
Tidskriftsartikel (refereegranskat)abstract
- Reducing the risk posed by mixtures of pharmaceuticals is a goal of current initiatives such as the European Green Deal to reduce anthropological environmental impacts. Wastewater effluent typically contains large numbers of active pharmaceutical ingredients (APIs). For some APIs, existing technology such as conventional activated sludge (CAS) wastewater treatment plants (WWTPs) have removal rates below 20 %, thus the WWTP discharges are adding to the toxic burden of receiving waters.We present an environmental risk assessment of mixtures of 35 APIs in effluent samples from 82 Northern European WWTPs using the concentration addition model, and identify the respective risk-driving APIs. This is then compared to a corresponding mixture risk assessment of effluent samples from the Danish Hillerod WWTP subjected to post-treatment with varying specific ozone doses (0.15-1.05 mgO3/mgDOC) and/or granulated activated carbon (GAC). All 82 WWTP effluent samples exceeded risk thresholds by at least a factor of 30, with a median RQSUM of 92.9, highlighting the need for effluent post-treatment and/or a substantial dilution in the recipient waters. Antibiotics, analgesics and anti-depressants were among the top risk drivers with 99 % of the average mixture risk attributable to azithromycin, diclofenac, venlafaxine, clarithromycin and mycophenolic acid. Effluent mixture risk was reduced by ozonation in a concentration-dependent manner, decreasing below threshold levels to a median RQSUM of 0.83 following treatment with 0.65 mgO3/mg DOC. Fresh GAC was also effective atreducing the mixture risk both alone and with ozone treatment, with median RQSUM of 0.04 and 0.07 respectively.To our knowledge, this is the first study to present a risk assessment of pharmaceutical mixtures in effluent comparing "conventional" WWTP processes with additional post-treatment with ozone and/or GAC for reducing the joint risks of pharmaceutical mixtures for recipient waters. We demonstrate the need for additional WWTP treatment technologies, and the efficacy of GAC and ozonation in decreasing the risk to the aquatic environment from pharmaceutical mixtures to below acceptable threshold limits.
|
|
| 5. |
- Wells, Fred E., et al.
(författare)
-
Annual and decadal surveys of molluscs on intertidal platform reefs in a warming marine environment in the southeastern Indian Ocean provide a baseline for monitoring for future environmental changes
- 2024
-
Ingår i: Molluscan Research. - 1323-5818.
-
Tidskriftsartikel (refereegranskat)abstract
- Few data sets are available to evaluate short- and long-term perturbations and impacts of increasing anthropogenic stresses and a warming marine environment in coastal regions near cities. The Perth, Western Australia shoreline has extensive, depauperate sandy beaches interrupted by small, biodiverse intertidal reef platforms. We present transect data on mollusc diversity and density on three Perth platforms recorded from 1983 to 1987, and compare it to 2007 and 2021 to analyse assemblage modifications in response to increased anthropogenic pressures. NMDS multivariate analysis showed a consistent drift in assemblage composition in 2007 and 2021, but this is was not statistically significant from the 1980s baseline (PERMANOVA, P = 0.336). There was no significant long-term decline (or increase) in molluscan species richness. Most species were uncommon but eight were recorded on at least 20 of the 21 surveys. The endemic Western Australian mussel Brachidontes ustulatus (Lamarck, 1819) accounted for 71.8% of all individuals. Total mollusc density varied primarily with changes in B. ustulatus. Tropical species were a minor component of the molluscs that did not change in diversity with warming temperatures. These data provide a long-term baseline for monitoring future anthropogenic changes.
|
|
